Diagnóstico y tratamiento de una tuberculosis pulmonar cavitada en un lactante / Insulin pump therapy in a 21-month-old boy

No disponible

Reflujo gastroesofágico en el niño: manejo nutricional y farmacológico / Gastroesophageal reflux in children: nutritional and pharmacological management

El reflujo gastroesófágico (RGE) constituye uno de los motivos más frecuentes de consulta en las unidades de gastroenterología infantil. Afortunadamente, en la mayoría de los niños, se trata de una entidad que no afecta a su desarrollo y que se resuelve en los primeros meses de vida. No obstante, determinado número de niños desarrolla complicaciones derivadas de este reflujo, que denominamos enfermedad por reflujo gastroesofágico (ERGE). La prevención de estas complicaciones y su adecuado tratamiento constituyen los pilares fundamentales para evitar el desarrollo de situaciones de difícil solución o la necesidad de cirugía. En este trabajo se revisan la fisiopatología del RGE, sus manifestaciones clínicas y se hace especial referencia al tratamiento nutricional y farmacológico (AU)

[The role of IgA and IgA antigliadin antibodies in the diagnosis and management of celiac disease]. / Importancia de los anticuerpos antigliadina de tipo IgA e IgG en el diagnóstico y seguimiento de la E. celíaca.

The authors reports the results of ELISA IgG and IgA antigliadin antibodies measurements in a study of 271 serum samples proceeding from celiac patients (with and without gluten containing diet) and control subjects. IgA antigliadin antibody measurement had the most specificity and positive predictive value, IgG antigliadin antibody measurement had the most sensitivity and negative predictive value. Our results point out that antigliadin antibodies are helpful in the diagnosis and management of celiac disease. Un the same manner, antigliadin antibodies are helpful to evaluate the adherence of patients to gluten-free diet.

[Anti-endomysium antibodies: new serological markers for the diagnosis and follow-up of patients with gluten-sensitive enteropathy. Preliminary study]. / Anticuerpos antiendomisio: un nuevo marcador serológico para el diagnóstico y seguimiento de pacientes afectos de enteropatía sensible al gluten. Estudio preliminar.

The authors value the parameters of diagnostic efficacy in a preliminary study of anti-endomysium antibodies (EmA), in the diagnostic and follow-up of patients with gluten sensitive enteropathy. The study was made with 84 subjects distributed into four groups. Group I consisted of 21 patients with gluten sensitive enteropathy (GSE) who were eating gluten at the time of diagnosis. Group II consisted of 20 patients with gluten sensitive enteropathy with different periods of time of gluten free diet. Group III consisted of 16 subjects with non-evolutive neuropathies and without intestinal disease. This group was considered as controls. Group IV consisted of 27 patients with toddler diarrhoea. The sensitivity, specificity, positive predictive value, negative predictive value and efficiency were 100%.

[Primary peptic ulcer in childhood: apropos of 20 cases studied using digestive fiberendoscopy]. / Ulcus péptico primario en la infancia: a propósito de 20 casos estudiados mediante fibroendoscopia digestiva.

We report a review of 20 children (14 males and 6 females) between 3 1/2-13 years of age (mean 9.7/ 12 years) with primary peptic ulcer disease, diagnosed by digestive fiberendoscopy. Endoscopy revealed 18 duodenal and 2 gastric ulcers. Positive family history was found in 45% of the patients. Abdominal pain was the most common presenting symptom and gastrointestinal bleeding was the only complication. The time before diagnosis was lesser than one month in 10%, between one to six months in 30% and more than months in 60% of patients. The follow-up period rate from three to 46 months (mean 14.9/12 months). Radiological study was performed in 18 patients and led 50% of false negative. A satisfactory response to mean treatment was found in all cases. Three patients related No patients required surgical treatment.